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A B S T R A C T
Increasing levels of antimicrobial resistance in human and veterinary medicine have raised concerns around the
issue of overprescribing and the indiscriminate use of antimicrobials. Their use in food producing animals is
under scrutiny due to the perceived risk from the zoonotic transfer of resistant pathogens from animals to
humans. This study aimed to explore UK veterinary surgeons antimicrobial prescribing behaviours, their atti-
tudes to antimicrobial resistance and their perceptions of responsibility of antimicrobial use in pigs through a
questionnaire study on a census sample of 261 veterinary surgeons in England, Wales and Scotland who had a
clinical caseload which included commercial pigs. The questionnaire had a useable response rate of 34.1%
(n=61/179) in eligible veterinary surgeons.
Overall, veterinary surgeons reported personal confidence that their prescribing decisions were responsible
however, there was concern that the prescribing behaviours of other veterinary surgeons and physicians in
human medicine may be less responsible; a sociological concept known as ‘othering’. In parallel, veterinary
surgeons seldom identified that treatment failure was a consequence of antimicrobial resistance in their own
clinical caseload, however they considered it an issue for other veterinary surgeons and for human prescribers.
Veterinary surgeons consulted a wide spectrum of resources on antimicrobial use in pigs which, on occasion,
contained conflicting guidance on what was defined as responsible prescribing. The decision over whether or not
to prescribe an antimicrobial was influenced by numerous factors relating to the veterinary surgeons’ experience
and the clinical situation presented, but maintaining pig welfare was a high priority. There was a shared desire to
seek alternative methods to prevent disease to antimicrobial use, however the use of diagnostics to support
prescribing decisions was an infrequently reported behaviour and could play a more significant role in prescriber
decisions if more cost effective and rapid tests were available.
Future interventions to optimise antimicrobial use in pigs needs to focus on the evolution of antimicrobial use
practices in a changing political and scientific landscape whilst also considering individual motivations and
justifications for use.
1. Introduction
The emergence of resistant bacteria in human and veterinary med-
icine has highlighted the need to ensure that antimicrobial use is
minimal and prudent (Burow et al., 2014; Peeters et al., 2015; Tang
et al., 2017). Whilst it is not possible to quantify the risk to human
health, from antimicrobial use in livestock, there is growing concern
over the potential public health risks (O’Neill, 2016; Tang et al., 2017;
Aidara-Kane et al., 2018). Antimicrobial use characteristics in the pig
sector, such as the comparatively high sales of products, the adminis-
tration of in-feed antimicrobials (European Medicines Agency, 2017;
VMD, 2017) and frequent prophylactic use (Callens et al., 2012), have
highlighted pigs as a priority species for gaining understanding of an-
timicrobial use behaviours and seeking ways in which use can be re-
duced (Postma and Stärk, 2015; Visschers et al., 2015, 2016). Conse-
quently, there is increased political pressure for policy measures to
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reduce antimicrobial use in pigs (O’Neill, 2016; RUMA, 2017), as well
as other livestock species.
Guidelines on the use of antimicrobials in pigs have been produced
by both the Pig Veterinary Society (PVS) and Responsible Use of
Medicines in Agriculture Alliance (RUMA), to promote prudent pre-
scribing practices and advise on alternative methods to treat and pre-
vent disease (RUMA, 2013; PVS, 2014). However, at present there are
currently no guidelines available in the UK which advise on appropriate
antimicrobial choices for different disease conditions in pigs. For ex-
ample, the PVS guidelines recommend that the use of antimicrobials
classified as critically important to human health are only used if other
antimicrobial classes are not available or effective. These guidelines
follow the European Medicines Agency antimicrobial expert group
(AMEG) definition of critically important antimicrobials and include
the fluoroquinolones, third and fourth generation cephalosporins and
colistin (PVS, 2014; NOAH, 2016). At the time of dissemination of the
questionnaire the authors adopted the current World Health Organi-
sation’s (WHO)definition of highest priority critically important anti-
microbials (HP-CIAs) from the fourth edition of the ‘Critically Im-
portant Antimicrobials for Human Medicine’ which included the
fluoroquinolones, third and fourth generation cephalosorins and the
macrolide antimicrobials. However, it did not include colistin (WHO,
2013).
Clinical factors such as the pharmacological characteristics of anti-
microbials, antimicrobial susceptibility testing (AST) results, clinical
disease signs and predicted outcomes have been found to motivate
antimicrobial use decisions in both human (Coenen et al., 2002;
Teixeira Rodrigues et al., 2013) and veterinary medicine (Busani et al.,
2004; Speksnijder et al., 2015a; Coyne et al., 2016). Non-clinical factors
also influence antimicrobial use decisions in both humans and animals
such as a practitioners’ perception of responsible prescribing beha-
viours, fear of clinical signs worsening should antimicrobials not be
prescribed, professional stress and client compliance (Busani et al.,
2004; Gibbons et al., 2013; Teixeira Rodrigues et al., 2013; Coyne et al.,
2016). Studies have attempted to quantify antimicrobial use and in-
vestigate the influences behind antimicrobial use practices in food
producing animal species (Dunlop et al., 1998; Busani et al., 2004;
Stevens et al., 2007; Gibbons et al., 2013; Visschers et al., 2015, 2016),
however there has been little research investigating prescribing prac-
tices in the UK pig industry. The aim of this study was to determine the
behavioural influences and attitudes surrounding antimicrobial use
practices and responsibility in veterinary surgeons working with pigs in
the UK using a questionnaire survey.
2. Materials and methods
2.1. Questionnaire
The questionnaire design was guided by results from qualitative
interviews and focus groups with veterinary surgeons working in UK
pig practice (Coyne et al., 2014, 2016). The questionnaire was created
using the Adobe FormsCentral (Adobe Systems Incorporated, USA)
software and was available as both an electronic and paper format. The
questionnaire consisted of closed questions, 5 point likert scale state-
ments and open questions exploring antimicrobial prescribing beha-
viours, perceptions on antimicrobial resistance and participant per-
ceptions of what antimicrobial use behaviours are considered to be
responsible.
The questionnaire also included three common clinical disease
scenarios encountered in commercial pig veterinary practice. Questions
assessed the likelihood of respondents prescribing antimicrobials using
a 5-point likert scale and requested the first and second antimicrobial
choices using an open question for each scenario. An open question was
used to ensure that respondents volunteered antimicrobial choices. Any
antimicrobial products reported by the trade name were reported in the
results as the appropriate antimicrobial active ingredient class.
Scenario one described Escherichia coli. (E. coli) scour in piglets on a
150 sow farrow-to-finish indoor slatted unit. The pathogen (E. coli) was
chosen for the scenario as it has been identified as a significant cause of
diarrhoea in neonatal piglets and is associated with significant mor-
bidity within affected herds (Luppi, 2017). Widespread resistance to E.
coli isolates have been identified across the UK including resistance to
spectinomycin, tetracyclines and trimethoprim sulphonamide anti-
microbials (VMD, 2015).
Scenario two described the observation of clinical signs of re-
spiratory disease in finishers on an indoor slatted unit. Respiratory
disease is a common driver for the use of antimicrobials in finishing
pigs (Stevens et al., 2007) and many outbreaks are identified as disease
syndromes commonly consisting of mixed viral and bacterial pathogens
(Holko et al., 2004; Haimi-Hakala et al., 2017).
Scenario three described neurological signs and meningitis asso-
ciated with Streptococcus suis (S.suis) in weaners on an indoor slatted
unit. S. suis is a common cause of meningitis, septicaemia and sudden
death in pigs and is widespread in much of the UK pig herd (Jackson
and Cockcroft, 2007; Goyette-Desjardins et al., 2014). Widespread an-
timicrobial resistance has been observed in the S. suis pig isolates
identified at UK government laboratories in 2014; high levels of re-
sistance were observed to tetracyclines, lincomycin, tylosin and tri-
methoprim/sulphonamide. However, all of these isolates were found to
be sensitive to penicillins (VMD, 2015).
The questionnaire content referred to the fourth revision of the
WHO ‘Critically Important Antimicrobials for Human Medicine’ con-
ducted in 2014 (WHO, 2013) which defined the fluoroquinolones, third
and fourth generation cephalosporins and macrolide antimicrobial
classes as HP-CIAs. However, it is worth noting that in the 2017 fifth
revision of these guidelines that the polymixin class, which includes
colistin, was added to the list of HP-CIA classes (WHO, 2017). In ad-
dition to the HP-CIAs colistin use was specifically assessed in the
questionnaire content due to its reported frequent use in pigs
(Timmerman et al., 2006; Callens et al., 2012), its increasing im-
portance in human medicine as an antimicrobial of last resort and the
concerns of the European Medicines Agency (EMA) who undertook a
review on colistin use in animals in 2013 (EMA, 2013).
The questionnaire was piloted on veterinary surgeons working
within the farm animal practice at the University of Liverpool. Ethical
approval was granted for the study from the University of Liverpool
Veterinary Science Research Ethics Committee and the Department for
the Environment Food and Rural Affairs (Defra) prior to the piloting of
the questionnaire.
The target population was all veterinary surgeons who conducted
commercial pig veterinary work in England, Wales and Scotland. All
veterinary practices on the Royal College of Veterinary Surgeons
(RCVS) veterinary practice database (RCVS, 2014) which indicated
they undertook pig work were contacted by telephone to confirm that
their caseload included some pig work and to obtain the names of ve-
terinary surgeons who saw commercial pigs which were then entered
into a database. The final sample consisted of 261 veterinary surgeons
across 104 veterinary practices.
An electronic version of the questionnaire was disseminated
through the PVS mailing list on the 4th September 2014 and a paper
questionnaire was sent to all veterinary surgeons in the sample who had
not already completed the questionnaire online on the 24th October
2014. A second copy of the questionnaire and covering letter was then
sent to non-responders on the 1 st December 2014.
2.2. Statistical analysis
Data analyses were completed using Microsoft Excel 2010
(Microsoft Corporation, Redmond, Washington, USA) and SPSS
Statistics 22.0 (IBM SPSS Statistics for Windows Version 22.0. Armonk,
NY: IBM Corp). Descriptive statistics including percentages for the re-
sponse categories and likert scale questions were produced for each
L.A. Coyne et al. Preventive Veterinary Medicine 161 (2018) 115–126
116
section of the questionnaire. Where numbers in outlying likert scale
categories were small, 5 point scale question categories were combined
to produce a 3 point scale response. For example, never, rarely, some-
times, often, always condensed to give the following categories; never
or rarely, sometimes, often or always. Chi-squared or Fishers Exact tests
(fewer than 5 expected responses in one or more categories) were used
to determine significant differences in responses between specialist pig
practitioners (100% pig caseload) or mixed species veterinary surgeons;
P values< 0.05 were deemed significant.
3. Results
3.1. Demographic information on respondent veterinary surgeons
In total 148 (56.7%) of 261 questionnaires were returned and, of
these, 61 were completed (7 electronically; 54 postal). The 87 non-
useable responses included being incomplete (n=2), in which the re-
spondent only completed the background information on themselves
and their practice and did not respond to any questions about anti-
microbial use, the veterinary surgeon reporting that they no longer had
a sufficient pig caseload (n=70), the veterinary surgeon no longer
working at the practice (n= 12) and the respondent wishing to opt out
of the study (n= 3). The useable response calculated after removing
these non-eligible responses (veterinary surgeons that no longer treated
pigs) was 34.1% (n= 61/179).
The clinical pig caseload of veterinary surgeons varied between
respondents with 32.7% (n= 20) spending 100% of their time under-
taking pig work whilst 57.5% (n= 29) of respondents spent less than
25% of their time working with pigs and the remainder between
26–99% (9.8%, n=12). The greatest percentage of respondents were
located in the Yorkshire and Humber region (23.6%, n= 17/61), the
North East (11.1%, n=8/61) and Eastern regions (11.1%, n=8/61);
reflecting the underlying population of pig veterinary surgeons in the
sample database.
The majority of veterinary surgeons were male (70.5%, n=43),
27.9% (n= 17) were female and n=1 chose not to disclose their
gender. The number of years of experience of veterinary surgeons
varied although 50.0% (n= 30) had qualified over 26 years ago. Over
half of the participants were senior veterinary surgeons (55.0%,
n=33), whilst 36.7% (n=22) were assistants and 8.3% (n= 5)
classified themselves as consultants specialising in pig medicine. A se-
nior veterinary surgeon is classified by the RCVS as having a role
overseeing the management of the veterinary practice or company,
including having a managerial role for assistant veterinary surgeons
employed (RCVS, 2012). Conversely, a consultant veterinary surgeon
works independently from a veterinary practice or company giving
veterinary advice on a self-employed basis. A minority of respondents
(14.7%, n= 9) had completed postgraduate study relating to pig
medicine, whilst 85.3% (n= 52) did not hold any relevant post-
graduate qualifications. A large proportion of respondents, 74.2%
(n=46/61), were members of the PVS.
3.2. Antimicrobial prescribing decisions
The most frequently volunteered sources of information by re-
spondents on antimicrobial use in pigs (Table 1) were the National
Office of Animal Health (NOAH) compendium (64%) and pharmaceu-
tical companies, others included the PVS and advice from colleagues.
35.1% (n=20/57) of respondents stated that their practice currently
had written prescribing guidelines for antimicrobial use in pigs.
The decision over whether or not to prescribe an antimicrobial was
influenced by a number of different factors relating to the veterinary
surgeons’ experience and the clinical situation presented (Fig. 1). The
majority of respondents identified that maintaining pig welfare, per-
sonal confidence in their diagnosis of a bacterial pathogen, advice from
senior colleagues and confidence that the farm staff will use
antimicrobials responsibly would be a positive driver towards the use of
an antimicrobial. Mixed species veterinary surgeons more frequently
held the opinion that a good relationship with the farmer
(P=<0.001), the farmer wanting antimicrobials (P= 0.035) and
confidence that the farm staff would use antimicrobials responsibly
(P= 0.011) would make them more likely to prescribe when compared
with specialist pig practitioners.
Antimicrobial prescribing choices were explored in the respondent
population through clinical disease scenarios (Table 2). There are pre-
sently no UK prescribing guidelines available which advise appropriate
antimicrobial choices for different clinical disease conditions in pigs.
Therefore, it was not possible to evaluate the appropriateness of pre-
scribing decisions described in these scenarios against any guidelines.
In scenario 1 (E.coli in piglets) 98% (n= 56/57) of participants were
either likely or very likely to prescribe antimicrobials. Aminoglycosides
were the most commonly described class of antimicrobials for use as a
first line therapeutic option whilst fluoroquinolones were the most
frequent second line choice. Overall, 16.7% (n=10/60) of the first line
and 42.2% (n=19/45) second line antimicrobial choices in this sce-
nario were categorised as HP-CIAs.
In scenario 2 (respiratory disease syndrome in finishers) around two
thirds of respondents (67%, n=36/54) were likely to prescribe anti-
microbials in this scenario. Tetracyclines were the most frequent first
line antimicrobial class chosen by participants whilst macrolides were
the second most common. The only HP-CIA class chosen were macro-
lides and these represented 15% of first line (n= 5/33) and 44% of
second line choices (n= 11/25).
In scenario 3 (S. suis in weaners) the majority of respondents (76%,
n=41/54) were likely to prescribe antimicrobials. Penicillins were the
most commonly chosen antimicrobial class for both first and second
line choices. The HP-CIA classes were only selected on 6.6% (n=3/45)
of occasions as a first and 10.3% (n=3/31) as a second line option.
3.3. Antimicrobial resistance
Veterinary surgeons held contrasting opinions on the possible ef-
fects of antimicrobial use in pigs (Table 3). The majority of veterinary
surgeons (67%) believed that antimicrobial use in pigs would increase
Table 1
The information sources on antimicrobial use in pigs cited by UK veterinary
surgeons respondents (n=59).
% of volunteered responses n
NOAH Compendium 63.9 39
Pharmaceutical company 50.8 31
PVS 27.9 17
Veterinary press 26.2 16
Colleagues 23.0 14
Veterinary pig medicine textbooks 19.7 12
Academic journals 14.8 9
Internet 11.5 7
Own experience 11.5 7
VMD 9.8 6
CPD 8.2 5
RUMA guidelines 8.2 5
AASV 3.3 2
AHDB Pork 3.3 2
APHA 1.6 1
IPVS 1.6 1
Red Tractor Farm Assurance 1.6 1
NOAH Compendium –National Office of Animal Health Compendium, PVS – Pig
Veterinary Society VMD – Veterinary Medicines Directorate, CPD – Continuing
Professional Development, RUMA – Responsible use of Medicines in Agriculture
Alliance guidelines, CPD – continuing professional development, AASV –
American Association of Swine Veterinarians, AHDB Pork- UK levy board re-
presenting pig production, APHA – Animal and Plant Health Agency, IPVS –
International Pig Veterinary Society.
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resistance levels in pigs; however, the impact on human resistance le-
vels divided opinion with only 45% rating it as important and 30% not
considering it to be important.
Veterinary surgeons reported that AST was a more frequent beha-
viour following treatment failure (Fig. 2). For example, when a bac-
terial infection was initially suspected AST was described as being
carried out frequently by under a fifth of veterinary surgeons; however,
this figure doubled if it was carried out following treatment failure.
Around half (51%) of respondents reported that they sometimes or
often encountered a lack of response to antimicrobials. Similarly,
around half of the respondents rarely or never considered that this lack
of response was due to antimicrobial resistance.
3.4. Responsible antimicrobial use behaviours
The majority of veterinary surgeons felt that the use of anti-
microbials for therapeutic or prophylactic reasons were either usually
or always justified as being responsible (Table 3). Similarly, 87% of
respondents felt that the use of in-feed antimicrobials were either
usually or always justified. Despite a 2006 ban on the use of anti-
microbials as growth promoters 4% felt this use was usually or always
justified (Table 3). Respondents reported that the continual medication
with antimicrobials from weaning until slaughter was less common in
pigs under their care (15% stated sometimes or often, n=9) compared
to the UK pig industry in general (71% stated sometimes or often,
n=33).
Veterinary surgeon opinion on the use of the HP-CIAs and colistin
varied. The majority of respondents perceived that the use of the
macrolide class and colistin was justified whereas around half of re-
spondents felt that the use of fluoroquinolones and third and fourth
generation cephalosporins were either rarely or never justified.
Specialist pig practitioners more frequently perceived that the use of
the macrolide class and colistin were justified when compared with
mixed species veterinary surgeons (P=<0.001).
Veterinary surgeon opinion varied when comparing the responsi-
bility of antimicrobial use in the pig sector with other veterinary sectors
(Table 4). However, mixed species veterinary surgeons more frequently
held the opinion that antimicrobial use in beef cattle (P= 0.001), dairy
cattle (P=0.01) and sheep (P= 0.02) were more responsible than in
pigs when compared to specialist pig practitioners.
Veterinary surgeons rated the importance of different actors for
monitoring and safeguarding the responsible use of antimicrobials in
pigs (Fig. 3). All respondents considered that veterinary surgeons and
farmers had an important role in ensuring that antimicrobial use was
prudent, whilst the majority also believed that farm assurance schemes
were important. However, opinion was divided on the role of the re-
tailer and the UK and EU governments.
3.5. Beneficial measures and barriers to the reduction of antimicrobial use
in pigs
Veterinary surgeon opinion on the potential effects of different
Fig. 1. UK pig veterinary surgeons opinion on factors likely to influence the decision of whether or not to prescribe an antimicrobial (n= 61).
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measures on total antimicrobial use in the UK pig industry are shown in
Table 5. The effects of policy measures produced mixed opinions. The
majority of veterinary surgeons considered that the concept of a penalty
system for high antimicrobial use farms and benchmarking anti-
microbial use between pig units would be beneficial in reducing anti-
microbial use in pigs. In contrast, the concept of ‘decoupling’ anti-
microbial dispensing and prescribing, whereby the veterinary surgeon
can prescribe but no longer dispense antimicrobials, was felt by the
majority to have no effect on reducing antimicrobial use in pigs.
However, banning in-feed premixed antimicrobials divided opinion
with half of respondents considering it to be beneficial. Mixed species
veterinary surgeons more frequently felt that a penalty system
(P= 0.01) would be beneficial in reducing antimicrobial use in the UK
pig herd when compared with specialist pig practitioners. Reducing
imports of pig meat from high antimicrobial use countries divided
opinion. However, mixed species veterinary surgeons more frequently
identified this to be beneficial when compared with specialist pig
practitioners (p=0.02).
The perceived effect of banning HP-CIA classes also divided opinion.
However, mixed species veterinary surgeons more frequently held the
opinion that banning the use of fluoroquinolones and third andfourth
generation cephalosporins would be beneficial in reducing anti-
microbial use in pigs when compared with specialist pig practitioners
(p= 0.001).
Over half of veterinary surgeons did not consider economic factors
such as either increasing or decreasing the cost of antimicrobials for
farmers would have any effect on the total amount of antimicrobials
used in pigs. The impact of increasing the profitability of pig meat
prices on total antimicrobial use in pigs divided opinion amongst re-
spondents with some identifying it as a benefit whilst others identified
it as having no effect or a barrier.
Overall, most respondents felt that modernising indoor pig accom-
modation and locating pig units in areas that are isolated from other pig
farms were beneficial in minimising antimicrobial requirements.
However, the consequences of increasing the use of outdoor breeding
and straw-based finishing systems resulted in a spectrum of opinions
amongst participants. The majority of participants considered alter-
native methods of preventing disease such the availability of more ef-
fective and a wider range of vaccinations, and de-populating and re-
populating low health status pig herds with higher health status stock to
Table 2
UK veterinary surgeon antimicrobial prescribing decisions in 3 clinical disease scenarios.
aHP-CIA classes as defined by the fourth edition of the ‘Critically Important Antimicrobials for Human
Medicine’ as was current at the time that the questionnaire was conducted (WHO, 2013).
bHP-CIA classes defined in the fifth edition of the Critically Important Antimicrobials for Human Medicine’
published in 2017 which post-dates the questionnaire study.
L.A. Coyne et al. Preventive Veterinary Medicine 161 (2018) 115–126
119
be beneficial in reducing overall antimicrobial use in pigs.
Farmer reluctance to change current practices was frequently
identified as a barrier to reducing use; however, the majority of re-
spondents felt that veterinary surgeons educating farmers on herd
health improvements would be beneficial in reducing antimicrobial use
in pigs. Mixed species practitioners identified farmer reluctance as a
barrier significantly more commonly than specialist pig veterinary
surgeons (p= 0.001).
4. Discussion
This study identified that veterinary surgeons’ antimicrobial pre-
scribing decisions were influenced by a range of factors. Factors iden-
tified such as the veterinary surgeons’ confidence in their diagnosis, and
a desire to avoid the negative welfare implications of disease, are also
commonly described in human and veterinary medicine (Coenen et al.,
2002; De Briyne et al., 2013), and are motivated by the prescribers’
Table 3
UK pig veterinary surgeons’ perceptions on the effects on antimicrobial resistance levels in production animals, humans and pigs from antimicrobial use in pigs and
antimicrobial use behaviours that were considered to be justified and exemplify the responsible use of antimicrobials in pigs.
Veterinary surgeon perceptions on the effects on antimicrobial resistance levels in production animals, humans and pigs from the use of antimicrobials in pigs (n= 60)
Not important Not very important Neutral Quite important Very important
Increased antimicrobial resistance in other production animal species 3 (5%) 8 (13%) 18 (30%) 18 (30%) 13 (22%)
Reduced risk of disease transmission to human beings 6 (10%) 7 (12%) 16 (27%) 21 (35%) 10 (17%)
Increased antimicrobial resistance in human beings 5 (8%) 13 (22%) 15 (25%) 12 (20%) 15 (25%)
Increased antimicrobial resistance in pigs 3 (5%) 2 (3%) 15 (25%) 18 (30%) 22 (37%)
Antimicrobial use behaviours which were considered by veterinary surgeons to be justified and exemplify the responsible use in antimicrobials in pigs.
Never justified Rarely justified Usually justified Always justified Unsure
The use of the fluoroquinolones in pigs (n= 55) 1 (2%) 24 (44%) 22 (40%) 4 (7%) 4 (7%)
The use of the colistin in pigs (n=53) 3 (6%) 9 (17%) 26 (49%) 7 (13%) 8 (15%)
The use of third and fourth generation cephalosporins in pigs (n= 56) 1 (2%) 25 (45%) 22 (39%) 4 (7%) 4 (7%)
Use of macrolides (n=56) 0 (0%) 8 (14%) 34 (60%) 11 (20%) 3 (5%)
Antimicrobial use for therapeutic reasons (n= 58) 0 (0%) 0 (0%) 15 (36%) 42 (72%) 1 (2%)
Antimicrobial use for prophylactic reasons (n= 58) 2 (3%) 13 (22%) 36 (62%) 3 (5%) 4 (7%)
Antimicrobial use to increase growth rates or production (n=58) 33 (57%) 20 (34%) 1 (2%) 1 (2%) 3 (5%)
The use of in-feed antimicrobials in pigs (n=58) 0 (o%) 7 (12%) 44 (76%) 4 (7%) 3 (5%)
Fig. 2. Frequency of UK pig veterinary surgeon reported behaviour with regards to AST and treatment failure (n= 61).
L.A. Coyne et al. Preventive Veterinary Medicine 161 (2018) 115–126
120
personal and professional responsibility (Busani et al., 2004, Mattick
et al., 2014). Veterinary surgeons identified themselves and farmers to
be the most important actors in monitoring responsible antimicrobial
use in pigs identifying them as the most relevant target groups for in-
terventions to promote prudent prescribing practices.
The veterinary surgeon-farmer relationship and confidence in the
farmers’ ability to administer antimicrobials responsibly were more
commonly considered to be a factor that motivated prescribing by
mixed species veterinary surgeons when compared with specialist pig
practitioners. This may reflect that mixed species veterinary surgeons’
livestock caseloads are likely to be predominantly ruminants, which
typically require more individual veterinary visits when compared with
pig herds which are managed at a population level (Kelliher et al.,
2014). There are parallels with the human medicine definitions of
‘patient-centred’ and ‘population-centred’ care (Stiefel and Nolan,
2012), therefore, it may be that mixed species practitioners are utilising
a more patient-centred approach, which could result in a closer veter-
inary surgeon-farmer relationship due to the more frequent farm visits
and communication in ruminant species practice (Harwood et al.,
2016). In addition, respondents working in mixed practice identified
that they would be more likely to prescribe if they believed the farmer
wanted antimicrobials compared with the specialist veterinary surgeon.
However, this finding contrasts with the conclusions of Postma and
Speksnijder, 2016 that veterinary surgeons specialised in intensive li-
vestock species (pigs and poultry) felt a greater pressure from farmers
to prescribe when compared with veterinary surgeons undertaking
predominantly ruminant work (Speksnijder et al., 2015a).
Veterinary surgeons most frequently consulted the NOAH
Compendium of Data Sheets for Animal Medicines and pharmaceutical
companies for information on antimicrobial use in pigs. These sources
offer guidance on the choice of an appropriate antimicrobial for the
presenting condition, appropriate dosage and course length and the
recommendation that HP-CIAs should be reserved for use when other
antimicrobial classes are either ineffective or where clinical response is
expected to be poor (Paskovaty et al., 2005; NOAH, 2014). However,
they do not offer guidance on the potential over-use of broad-spectrum
antimicrobials and do not advise on which specific antimicrobial classes
should be used as first line options in pig practice (Paskovaty et al.,
2005). The aforementioned guidance is included in the PVS prescribing
principles, which were consulted by less than a third of respondents and
offer advice on which classes of antimicrobial should be chosen as first,
second and third line options and when AST should be conducted prior
to the use of certain classes (PVS, 2014). Research in the cattle, horse
and small animal sectors in the UK has also found that respondents
consulted the NOAH Compendium and pharmaceutical companies more
frequently than veterinary associations for information on anti-
microbial prescribing (Hughes et al., 2012, 2013; Williams et al., 2012).
Veterinary surgeons frequently cited pharmaceutical companies as a
source of information on antimicrobials in pigs. In agreement, a study
into antimicrobial use behaviours in Flanders and the Netherlands
showed that around half of veterinary surgeons considered pharma-
ceutical companies influenced their antimicrobial prescribing decisions
in farm animal practice (Postma and Speksnijder, 2016). Evidence from
human medicine demonstrates divided opinion on the influence of
pharmaceutical companies on antimicrobial prescribing decisions with
some sources identifying it as a pressure on prescribing practice
(Paredes et al., 1996; Barden et al., 1998), whilst other studies con-
sidered them to have little or no effect on behaviours (Simpson et al.,
2007; Lopez-Vazquez et al., 2012). The relationship between senior and
assistant veterinary surgeons may also influence prescribing decisions.
For example, respondents identified that advice from senior colleagues
was a positive driver towards antimicrobial use decisions. Similarly, in
human medicine it has been shown that senior physicians have a sig-
nificant influence on junior doctors’ antimicrobial prescribing beha-
viours (Sterkenburg et al., 2010; Santana et al., 2011).
The importance of diagnostic testing in identifying the pathogen
responsible for clinical disease signs and ascertaining an appropriate
antimicrobial are essential tools in ensuring that antimicrobial use is
appropriate. However, AST was described by respondents as being
utilised infrequently, although it was reported to be more frequent
following initial treatment failure. Factors relating to the time delay in
obtaining the results from such diagnostics and cost may be a hurdle to
their frequent adoption (De Briyne et al., 2013; Speksnijder et al.,
2015a; Coyne et al., 2016). Diagnostic testing has been identified as an
underutilised tool in both veterinary (De Briyne et al., 2013; Coyne
et al., 2016) and human medicine (Peterson and Dalhoff, 2004). There
is a need for further research to identify cost effective, rapid pen-side
tests to identify the pathogens responsible and their susceptibility
profiles to determine the appropriate antimicrobial to use.
In parallel with other studies in human and veterinary medicine,
veterinary surgeons seldom considered treatment failure as being a
major issue in their clinical practice (Simpson et al., 2007; Buller et al.,
2015; Speksnijder et al., 2015a). Additionally, when respondents
Table 4
UK pig veterinary surgeon combined opinions on how responsibly anti-
microbials are used in other veterinary sectors when compared with the pig
sector.
Less responsibly Neutral More responsibly
Beef cattle (n=53) 7 (13%) 23 (43%) 23 (44%)
Dairy cattle (n= 54) 12 (22%) 22 (41%) 20 (37%)
Equine (n= 50) 14 (28%) 20 (40%) 16 (32%)
Poultry (n= 48) 14 (29%) 24 (50%) 10 (21%)
Sheep (n= 51) 11 (22%) 22 (43%) 18 (35%)
Small animals (n= 53) 23 (44%) 18 (33%) 12 (23%)
Fig. 3. UK Veterinary surgeons’ ratings of which actors are important in monitoring responsible antimicrobial use in pigs (n= 61).
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encountered inefficacy of antimicrobials they rarely attributed this to
antimicrobial resistance. Buller et al., (2015) described a similar phe-
nomenon whereby veterinary surgeons generally did not consider an-
timicrobial resistance to be the primary cause of treatment failures,
while studies in human medicine show that physicians do not consider
antimicrobial resistance to have a major effect on their clinical work
and it was infrequently considered in prescribing decisions (Simpson
et al., 2007; Wood et al., 2013). Such beliefs that antimicrobial re-
sistance is not a major issue in clinical pig practice, and that treatment
failures are not a consequence of antimicrobial resistance, may act as a
barrier to implementing policies advocating behaviour change to pro-
mote responsible antimicrobial use.
As is shown in the literature the majority of livestock veterinary
surgeons acknowledged that increased antimicrobial resistance in hu-
mans is a potential consequence from the use of antimicrobials in pigs
(Cattaneo et al., 2009; Speksnijder and Jaarsma, 2015; Visschers et al.,
2016). However, Speksnijder et al. (2015b) identified that many of the
farm animal practitioners in their study perceived indiscriminate pre-
scribing in human medicine to be the most significant driver of anti-
microbial resistance in humans. These respondents stated that they
seldom saw treatment failure in everyday clinical practice and as such
felt that overuse use by physicians was likely to be the most significant
driver for antimicrobial resistance in human medicine.
The perception held by respondents that antimicrobial use in pigs
may actually reduce the risk of disease transmission to humans is
supported by the theory that antimicrobial use in livestock may reduce
microbial load and shedding, and thus, may lead to a lower frequency
of meat products and environmental contamination with zoonotic pa-
thogens (Landers et al., 2012). However, such theories are poorly
supported in published studies and the negative public health con-
sequences from the zoonotic transfer of resistant bacteria from livestock
to humans are well documented (Taylor et al., 2008; Burow et al., 2014;
Liu et al., 2016; Tang et al., 2017). Thus, this shows a mismatch be-
tween scientific evidence and veterinary surgeon perceptions. Such
perceptions may be driven by previous public health initiatives which
focused on reducing microbial load in livestock species and meat;
antimicrobial administration was one route through which Salmonella
pathogen reduction was advocated for poultry (Van Immerseel et al.,
2002).
Prescribing practices which have been highlighted through political
and media pressure, such as the use of in-feed antimicrobials, prophy-
lactic antimicrobial use, and the use of the HP-CIAs, were considered by
the majority to be justifiable (O’Neill, 2015; Morris et al., 2016). In-feed
antimicrobials are frequently used for disease prevention in pigs and
whilst this use is generally perceived to be prudent by veterinary sur-
geons (Callens et al., 2012; Speksnijder and Jaarsma, 2015), there has
been an increasing focus on research seeking alternative methods of
preventing disease in pigs (EIP-AGRI, 2015; Postma and Stärk, 2015).
The literature identifies vaccination as a feasible alternative method
of preventing disease to antimicrobial use in pigs (Buller et al., 2015;
Postma and Stärk, 2015) and veterinary surgeons in this study identi-
fied that improvements in the efficacy and availability of vaccinations
would be beneficial in reducing antimicrobial use. However, it is per-
haps a simplistic view to consider vaccinations to be the answer to
reducing antimicrobial use with a number of studies correlating more
frequent vaccination use with higher antimicrobial use on farm
(Stevens et al., 2007; Postma and Backhans, 2016; Temtem et al.,
2016); these conclusions may reflect that pig herds with a greater
prevalence of endemic disease and higher antimicrobial use are more
likely to vaccinate. Another essential tool in minimising the anti-
microbial requirement of a farm is ensuring that both internal and ex-
ternal farm biosecurity are optimal (Postma and Backhans, 2015, 2016;
Collineau et al., 2017). Whilst biosecurity was not specifically covered
in the questionnaire content it is major focus of recent efforts to reduce
the burden of disease and antimicrobial use in UK pig production
(RUMA, 2017).
Veterinary surgeons expressed concern that antimicrobial use may
be less responsible by other practitioners within the pig industry. This
concept in which such irresponsible prescribing behaviours are not
identified in the prescribers’ own behaviours, but are described as being
more frequent in a distinct societal group, other pig veterinary surgeons
or in other species sectors, is a social construct referred to as othering
Table 5
Veterinary surgeon opinion on whether different measures would be considered to be a barrier, beneficial or have no effect on the total amount of antimicrobial used
in pigs in the UK.
Barrier Neutral, no effect Beneficial
Behavioural factors
Farmer reluctance to change current practices (n= 60) 50 (83.3%) 8 (13.3%) 2 (3.3%)
Vet reluctance to change current practices (n= 60) 45 (75.0%) 14 (23.3%) 1 (1.7%)
Vets educating farmers on ways to improve herd health (n=58) 0 (0.0%) 4 (6.9%) 54 (93.1%)
Factors relating to potential policy
Banning in-feed antimicrobial formulations (n=57) 13 (22.8%) 15 (26.3%) 29 (50.9%)
A ‘penalty system’ of penalties for high antimicrobial usage in pigs, such as the “yellow card” system in Denmark (n=57) 7 (12.3%) 6 (10.5%) 44 (77.2%)
Banning the use of the fluoroquinolones and the third and fourth generation cephalosporins (n= 57) 11 (19.3%) 28 (49.1%) 18 (31.6%)
Banning the use of the macrolides (n= 57) 17 (29.8%) 23 (40.4%) 17 (29.8%)
A benchmarking system, whereby antibiotic usage is benchmarked between farms (n= 59) 3 (5.1%) 22 (37.7%) 34 (57.6%)
‘Decoupling’ the dispensing and prescribing of antimicrobials so that vets are no longer able to dispense antimicrobials directly
and can only prescribe antimicrobials to clients (n= 58)
14 (24.1%) 40 (69.0%) 4 (6.9%)
Further controls on the licensing of cheaper generic antimicrobial products (n= 59) 3 (5.2%) 37 (63.8%) 18 (31.0%)
Reducing imports from other countries with high antimicrobial use (n= 59) 2 (3.4%) 23 (39.0%) 34 (57.6%)
Factors relating to management
Eradicating swine dysentery from the UK (n=58) 1 (1.7%) 9 (15.3%) 49 (83.1%)
Modernising indoor pig accommodation (n= 58) 0 (0.0%) 5 (8.5%) 54 (91.5%)
Increased use of straw-based finishing systems (n= 58) 10 (17.2%) 30 (51.7%) 18 (31.0%)
Increased use of outdoor breeding systems (n=57) 5 (8.6%) 37 (63.8%) 16 (27.6%)
More effective vaccines (n= 61) 0 (0.0%) 2 (3.4%) 56 (96.6%)
A wider range of vaccines (n= 59) 0 (0.0%) 2 (3.5%) 55 (96.5%)
De-populating and re-populating low health status pig herds with higher health status stock (n=59) 0 (0.0%) 6 (9.8%) 55 (90.2%)
Locating pig units in areas that are isolated from other units (n= 58) 0 (0.0%) 10 (16.9%) 49 (83.1%)
Factors relating to economics
Increased profitability of pig meat price (n= 58) 5 (8.5%) 21 (35.6%) 33 (55.9%)
Increasing the cost of antimicrobials for farmers (n=58) 7 (12.1%) 34 (58.6%) 17 (29.3%)
Decreasing the cost of antimicrobials for farmers (n= 59) 21 (36.2%) 36 (60.3%) 2 (3.4%)
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(Sibley, 1998; Johnson et al., 2004); and is a recognised concept in
human medicine (Barden et al., 1998; Butler et al., 1998; Teixeira
Rodrigues et al., 2013). For example questionnaire respondents per-
ceived that they themselves did not practice continual and long-term
antimicrobial use but felt that such practices may be more common
elsewhere in the UK pig industry; whilst such long-term and habitual
use behaviours have been described in the pig industry (Visschers et al.,
2014; Buller et al., 2015) they are not consistent with the current UK
guidelines on the responsible use of antimicrobials in pigs (RUMA,
2013; PHWC, 2015).
There has been increasing pressure on the veterinary profession that
use of the HP-CIAs should be restricted in livestock (O’Neill, 2016;
WHO, 2017) and in agreement, the PVS prescribing principles re-
commend that these classes are not used as first line antimicrobial
choices (PVS, 2014). However, the consensus opinion amongst re-
spondents was that their use in pigs was responsible and justified.
Additionally, HP-CIAs were seldom chosen as a treatment option in the
clinical disease scenarios with the exception of E.coli scour in piglets
whereby fluoroquinolones were a more frequent choice (15% of re-
spondents as a first line choice and 36% as a second line choice). This
may reflect the high resistance levels in E. coli to spectinomycin, an
alternative authorised treatment option, described in national scanning
surveillance and research studies (Österberg et al., 2016; VMD, 2017).
Thus, any such restrictions on HP-CIA use are likely to have a sig-
nificant impact on the pig industry. For example in the aforementioned
example restricting fluoroquinolones will limit the number of effective
treatment options for E.coli scour in piglets with potential negative
health and welfare implications for piglets.
Specialist pig veterinary surgeons more frequently identified that
the use of colistin was justified in pigs when compared with mixed
species practitioners and its overall use was infrequently described in
the clinical disease scenarios. This may reflect its comparatively
common use in pigs when compared with other species (De Briyne
et al., 2014; Benstetter, 2016). However, it should be noted that the
discovery of the ability of the mcr-1 gene to transfer resistance via a
plasmid-mediated polymyxin resistance mechanism occurred in 2015
after this study was completed (Liu et al., 2016; AbuOun et al., 2017;
Hadjadj et al., 2017), and the use of colistin has since been voluntarily
restricted by UK livestock industries (Anon, 2015), with the initiative
resulting in an 83% reduction between 2015 and 2016 (VMD, 2017).
The policy approach taken by the UK to regulate antimicrobial use
through voluntary initiatives and through farm assurance schemes
(RUMA, 2017) contrasts to Sweden, Denmark and the Netherlands
where antimicrobial use has been controlled through Government leg-
islation (Dupont et al., 2015; Dorado-García et al., 2016; Begemann
et al., 2017). Whilst it could be argued that the overall levels of ve-
terinary antimicrobial sales and use reductions observed in these
countries may suggest legislation is a more effective approach, this
opinion does not consider the complexities of the different political
environments and differences in livestock systems and animal demo-
graphics between countries (Begemann et al., 2017; European
Medicines Agency, 2017). For example, the voluntary approach taken
by the UK has already shown success with a 24% overall veterinary
antimicrobial sales reduction from 2014 to 2016 (VMD, 2017). Ad-
ditionally, in parallel to the UK, Belgium has adopted a voluntary ap-
proach to reducing antimicrobial use in livestock and has exhibited
success in both reducing antimicrobial use and antimicrobial resistance
in key food producing animal species (Postma and Speksnijder, 2016;
AMCRA, 2017).
The view that a legislative approach to antimicrobial use reduction
may not be appropriate for the UK is supported somewhat by the re-
spondents’ views which placed greater responsibility for monitoring the
prudent use of antimicrobials on voluntary farm assurance schemes
than on the UK or EU governments. Conversely, UK veterinary surgeons
felt that policy banning in-feed antimicrobials, benchmarking farms on
antimicrobial use and the use of a penalty system for high antimicrobial
users were likely to have a beneficial effect on reducing the total
amount of antimicrobials used in pigs. A penalty system whereby pro-
ducers are penalised for prolonged high antimicrobial use has been
successful in Denmark in reducing antimicrobial use in pigs (Aarestrup,
2012). This has been widely publicised and may have influenced the
respondent opinions. However, it is worth noting that since this ques-
tionnaire was conducted there has been a voluntary initiative to collect
antimicrobial use at pig farm level through the electronic medicines
book. This has shown an overall reduction in use in the UK pig herd of
50% between 2015 and 2017, thus, agreeing with respondent opinion
that benchmarking may be beneficial in reducing antimicrobial use
(Driver, 2018).
Veterinary surgeon attitudes to the efficacy of policy measures on
antimicrobials use in pigs may reflect underlying fears over potential
regulatory changes rather than respondents’ perceptions of actual ef-
fects from changes. For example, it could be considered that the ne-
gative respondent perception with regards to ‘decoupling’, as a policy
measure to reduce antimicrobial use, simply reflects veterinary sur-
geons’ underlying concerns over losing the ability to sell antimicrobials
directly to farmers. This concept is shown in a study by Postma et al.
(2016) which showed that the majority of veterinary surgeons in
Flanders and the Netherlands identified that retaining the right to sell
antimicrobials was a motivation to reducing antimicrobial use whilst
over 80% disagreed with legislation to ‘decouple’ antimicrobial use.
This uncertainty over the efficacy of ‘decoupling’ policy on the amount
of antimicrobials used in pigs is supported somewhat by the wide
spectrum of antimicrobial sales totals from across Europe in countries
that have introduced such legislation; ranging from Norway and
Sweden, with some of the lowest sales to Italy, with one of the highest
(EMA, 2015).
This underlying fear of policy changes may also have driven ve-
terinary surgeons opinion that restricting or banning the use of the HP-
CIA classes would have no effect on the total amount of antimicrobials
used in pigs in the UK. Contrary to this opinion evidence from Europe
shows that restricting these classes may have no effect on the health
and productivity of the national pig herd (EMA, 2014; Speksnijder and
Mevius, 2015). Similarly, recent research into HP-CIA use in UK dairy
cattle has shown that use can be discontinued whilst maintaining herd
health and productivity (Turner et al., 2018).
Concerns over antimicrobial resistance and the potential public
health effects from the use of antimicrobials in livestock, have con-
tinued to augment since this study was completed. These concerns have
been accelerated since the 2016 conclusion of the government com-
missioned Review on Antimicrobial Resistance by Lord O’Neill (O’Neill,
2016). The review recommended setting an antimicrobial use reduction
target for all livestock species to 50mg/PCU by 2018 from the 2014
baseline of 62mg/PCU (HM Government, 2016). Additionally, it re-
commended that species specific reduction targets were defined and in
response, the UK pig industry described a baseline figure of 263.5mg/
PCU for use in pigs for 2015. Consequently, the industry agreed a vo-
luntary reduction target to 99mg/PCU by 2020 (RUMA, 2017). In ad-
dition to the pressure on livestock industries to reduce total anti-
microbial use the O’Neill report also advised that the government
should consider restrictions or bans on the use of the HP-CIA classes in
agriculture (O’Neill, 2016). In response to these pressures the pig in-
dustry has taken a united approach to concerns over antimicrobial use
and have already achieved an overall reduction of 34% in all anti-
microbial classes and a reduction of 73% for fluoroquinolones, third
and fourth generation cephalosporins and colistin from 2015 to 2016
(VMD, 2017).
The efforts to reduce antimicrobial use across the pig sector com-
bined with the mounting pressures on the pig industry through negative
media and public perceptions may have resulted in changes to veter-
inary surgeon opinion since the questionnaire study was undertaken.
However, national and global concerns over antimicrobial resistance
continue to grow whilst the policy priorities continually evolve and
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change depending on the political and economic environment
(Christley et al., 2017). For example, due to growing concerns over
colistin resistance since the discovery of the mcr-1 gene the polymixin
class of antimicrobials have been re-classified by the WHO as a HP-CIAs
in the 2017 revision of the ‘Critically Important Antimicrobials for
Human Medicine’ (Liu et al., 2016; WHO, 2017). Therefore, whilst
some of the respondent beliefs and attitudes may have altered with time
these results still present the most up to date insights into antimicrobial
use practices by UK veterinary surgeons in pigs. Such detailed insights
into antimicrobial use behaviours by pig veterinary surgeons will assist
policy makers in identifying priority behaviours and areas to further
address the global threat of antimicrobial resistance.
In total 148 (56.7%) of 261 questionnaires were returned and of
these 61 were completed. The useable response calculated after re-
moving incomplete responses, responses where the veterinary surgeon
was no longer at the address or did not do sufficient pig work, was
34.1% (n= 61/179). In contrast, a questionnaire on antimicrobial use
in UK pig farms had a response rate of 25.5% (Stevens et al., 2007),
whilst a study on antimicrobial use by farm animal veterinary surgeons
had a response rate of only 17.1% (Williams et al., 2012).
The low questionnaire response rate may be related to the in-
creasing number of requests on veterinary surgeons to complete such
questionnaires and the time pressures faced by practitioners. In addi-
tion public, political and media pressure relating to antimicrobial re-
sistance have placed increasing pressure on the food producing animal
sector and veterinary profession; such pressure may result in a re-
luctance to share opinions (McCullough et al., 2015; Morris et al.,
2016). Both these factors indicate that future studies should aim for
collaborative approaches between research organisations and key sta-
keholders, thereby ensuring stakeholder engagement from the outset.
These pressures may also result in a potential bias in the respondent
population as veterinary surgeons that completed the questionnaire
may have a personal interest in antimicrobial use. In addition, there
may be limitations in self-reported behaviours, whereby participants
may respond to questions as they believe the authors expect them to,
rather than reporting actual practices may occur (Bowling, 2005).
5. Conclusions
This study highlights some parallels between antimicrobial use
practices in human and veterinary medicine, thus strengthening the
necessity that antimicrobial resistance is approached from a One Health
perspective. There is a need to reverse the current trend of human and
veterinary medicine blaming each other and to reduce the mounting
political and media pressure on the livestock sector. A One Health ap-
proach should encompass the health and welfare of humans and ani-
mals alike and consider the pressures currently facing the livestock
sectors.
The drivers behind antimicrobial prescribing decisions by pig ve-
terinary surgeons are multifactorial and complex. This study has iden-
tified the importance of non-clinical factors in influencing prescribing
behaviours such as the veterinary surgeon-client relationship and the
practitioners’ personal sense of responsibility. It has highlighted that
existing tools such as AST are underutilised and could play a more
significant role in prescriber decisions if more cost effective and rapid
tests were available. The wide range of information sources consulted
on antimicrobial use in pigs, and the contrasts between the prescribing
guidance contained in sources, highlight a need for uniform and com-
prehensive guidelines on the responsible antimicrobial use in pigs,
which are readily available to both specialist and mixed species veter-
inary surgeons. Future work should explore antimicrobial use in pigs
and needs to focus on the evolution of antimicrobial use practices in a
changing political and scientific landscape. Such research will assist
policy makers in targeting behaviours and areas to tackle the global
threat of antimicrobial resistance.
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